Johannes M. Respondek
Directeur Général chez OPTIPHARM Consulting Services GmbH
Profil
Johannes M.
Respondek currently works at OPTIPHARM Consulting Services GmbH, as Managing Director from 2004.
Dr. Respondek also formerly worked at SANOCHEMIA Pharmazeutika GmbH, as Deputy Chairman-Supervisory Board from 2014 to 2018, ICON Clinical Research GmbH, as Regional Director in 2000, Asta Pharma AG, as Director-Research & Development Coordination in 1991, Novartis AG, as Manager-Oncology Global Project Team in 1997, november AG, as Vice President-Medical Products Development in 2003, ASTA Medica AG, as Project Team Manager in 1996, and Degussa Corp., as Manager-Pharmaceuticals Business Development in 1987.
Postes actifs de Johannes M. Respondek
| Sociétés | Poste | Début |
|---|---|---|
| OPTIPHARM Consulting Services GmbH | Directeur Général | 28/09/2012 |
Anciens postes connus de Johannes M. Respondek
| Sociétés | Poste | Fin |
|---|---|---|
| SANOCHEMIA PHARMAZEUTIKA AG | Directeur/Membre du Conseil | 22/11/2018 |
november AG
 november AG Financial ConglomeratesFinance November AG is a holding company, which engages in the founding, acquisition, development, and management of companies. Its activities focus on the fields of medical, environmental, and biotechnology. It also supports the business development of its subsidiary companies and investments. The company was founded on November 26, 1996 and is headquartered in Cologne, Germany. | Corporate Officer/Principal | 01/01/2003 |
ICON Clinical Research GmbH
 ICON Clinical Research GmbH Pharmaceuticals: MajorHealth Technology Part of ICON plc, ICON Clinical Research GmbH is a clinical research organization that provides outsourced clinical development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. The company is based in Langen, Germany. The CEOs of the German company are Alan Sheehan, Christoph Zanke. | Corporate Officer/Principal | 01/01/2000 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/1997 |
| ASTA Medica AG | Corporate Officer/Principal | 01/01/1996 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Entreprise privées | 7 |
|---|---|
SANOCHEMIA Pharmazeutika GmbH
 SANOCHEMIA Pharmazeutika GmbH Pharmaceuticals: MajorHealth Technology SANOCHEMIA Pharmazeutika GMBH engages in the manufacture and distribution of pharmaceutical products. It operates through the following segments: Production, Human Pharmaceuticals, Veterinary Pharmaceuticals, Research and Development, and Others. The Production segment focuses on the synthesis of active pharmaceutical substances, drug formulation and pharmaceutical production. The Human Pharmaceuticals segment comprises of diagnostic activities including products such as X-ray and magnetic resonance imaging agents. The Veterinary Pharmaceuticals segment involves in veterinary medicine production, administration, and drug development. The Research and Development segment implements clinical trials and acquires licenses for the drugs. The company was founded by Werner Josef Frantsits on November 13, 1990 and is headquartered in Vienna, Austria. | Health Technology |
november AG
november AG Financial ConglomeratesFinance November AG is a holding company, which engages in the founding, acquisition, development, and management of companies. Its activities focus on the fields of medical, environmental, and biotechnology. It also supports the business development of its subsidiary companies and investments. The company was founded on November 26, 1996 and is headquartered in Cologne, Germany. | Finance |
| ASTA Medica AG | Health Technology |
Degussa Corp.
 Degussa Corp. Chemicals: Major DiversifiedProcess Industries Degussa Corp. manufactures chemical products. It products include anti-chlor agents and cleaning compounds. The company is headquartered in Theodore, AL. | Process Industries |
ICON Clinical Research GmbH
ICON Clinical Research GmbH Pharmaceuticals: MajorHealth Technology Part of ICON plc, ICON Clinical Research GmbH is a clinical research organization that provides outsourced clinical development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. The company is based in Langen, Germany. The CEOs of the German company are Alan Sheehan, Christoph Zanke. | Health Technology |
| OPTIPHARM Consulting Services GmbH | |
| Asta Pharma AG |
